Loperamide-induced enhancement of moxidectin availability in cattle

Journal of Veterinary Pharmacology and Therapeutics

Volumn 25, Issue 2, 2002, Pages 111-120

  Lifschitz, A ^b   Virkel, G ^b   Sallovitz, J ^b   Imperiale, F ^b   Pis, A ^b   Lanusse, C ^a  

^a Depto de Fisiopatologia   (Argentina)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN P; LOPERAMIDE; MOXIDECTIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTHROPOD; ARTICLE; BILE FLOW; BILE SECRETION; BOVIDS; CATTLE; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG EFFECT; DRUG FECES LEVEL; FLUORESCENCE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INTESTINE SECRETION; INTESTINE TRANSIT TIME; NEMATODE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANIMALS, NEWBORN; ANTI-BACTERIAL AGENTS; ANTIDIARRHEALS; ANTINEMATODAL AGENTS; AREA UNDER CURVE; BIOLOGICAL AVAILABILITY; CATTLE; CATTLE DISEASES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG SYNERGISM; FECES; INFUSIONS, INTRAVENOUS; INJECTIONS, SUBCUTANEOUS; LOPERAMIDE; MACROLIDES; MALE; NEMATODE INFECTIONS;

ANIMALIA; ARTHROPODA; BOS TAURUS; BOVIDAE;

EID: 0036098365     PISSN: 01407783     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2885.2002.00396.x     Document Type: Article

References (37)

1. The effect of level of feed intake on the pharmacokinetic disposition of oxfendazole in sheep
2. The effect of level of feed intake on the pharmacokinetic disposition and efficacy of ivermectin in sheep
3. Determination of moxidectin in plasma by high-performance liquid chromatography with automated solid-phase extraction and fluorescence detection
4. Involvement of MDR P-glycoprotein in the fate of endectocides in mice and rats
5. Enhanced absorption of pour-on ivermectin formulation in rats by co-administration of the multidrug-resistant-reversing agent verapamil
6. Interaction between fenbendazole and piperonyl butoxide pharmacokinetic and pharmacodynamic implications
7. Opioid agonists and antagonists
8. Liquid chromatographic determination of ivermectin with trifluoro-acetic anhydride and N-methylimidazole as the derivatization reagent
9. Decreased biotolerability for ivermectin and cyclosporin A in mice exposed to a potent P-glycoprotein inhibitors
10. The abamectin derivative ivermectin is a potent P-glycoprotein inhibitor
11. Pharmacokinetic disposition of benzimidazole drugs in the ruminant gastrointestinal tract
12. Modifying the formulation or delivery mechanism to increase the activity of anthelmintic compounds
13. The behaviour of doramectin in the gastrointestinal tract, its secretion in bile and pharmacokinetic disposition in the pheripheral circulation after oral and intravenous administration to sheep
14. Methimazole increases the plasma concentrations of the albendazole metabolites of netobimin in sheep
15. Relationship between pharmacological properties and clinical efficacy of ruminant anthelmintics
16. Influence on the antithyroid compound methimazole on the plasma disposition of fenbendazole and oxfendazole in sheep
17. Comparative plasma disposition kinetics of ivermectin, moxidectin and doramectin in cattle
18. P-glycoprotein and pharmacokinetics
19. Malnutrition modifies ivermectin disposition kinetics in calves
20. Moxidectin in cattle: Correlation between plasma and target tissues disposition kinetics
21. Chemotherapy and delivery systems-helminths
22. Effects of the multidrug-resistance-reversing agents verapamil and CL 347,099 on the efficacy of ivermectin and moxidectin against unselected and drug selected strains of Haemonchus contortus. in Jirds (Meriones Unguiculatus)
23. Verapamil modifies the pharmacokinetics of ivermectin in sheep
24. Reversal of P-glycoprotein-associated multidrug resistance by ivermectin
25. Opiod analgesics and antagonists
26. Fasting induced changes on the pharmacokinetic behaviour of albendazole and its metabolites in cattle
27. P-glycoprotein in nematodes
28. Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs
29. Absence of the mdr-1aP-glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin and cyclosporin A
30. P-glyco-protein in the blood-brain barrier of mice influences the brain penetration and pharmacological activity of many drugs
31. Structure and activity of avermectins and milbemycins in animal health
32. The role of MDR1 P-glycoprotein in the biliary and intestinal secretion of doxorubicin and vinblastine in mice
33. Genetic and biochemical evidence for a novel avermectin-sensitive chloride channel in Caenorhabditis elegans. Isolation and characterization
34. Ivermectin resistance in nematodes may caused by alteration of P-glycoprotein homolog
35. Absorption, tissue distribution, metabolism, and excretion of moxidectin in cattle